Scientific Letter
Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and Workflow
Registro y análisis en el tiempo de resultados clínicos en EPOC (Proyecto TRACE): metodología y procedimiento
Read
2457
Timeswas read the article
906
Total PDF
1551
Total HTML
Share statistics
array:23 [ "pii" => "S0300289620305159" "issn" => "03002896" "doi" => "10.1016/j.arbres.2020.10.022" "estado" => "S300" "fechaPublicacion" => "2021-09-01" "aid" => "2667" "copyright" => "SEPAR" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2021;57:593-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S0300289620305445" "issn" => "03002896" "doi" => "10.1016/j.arbres.2020.12.005" "estado" => "S300" "fechaPublicacion" => "2021-09-01" "aid" => "2690" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2021;57:594-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta Científica</span>" "titulo" => "Infección pulmonar por <span class="elsevierStyleItalic">Lophomonas blattarum</span>" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "594" "paginaFinal" => "596" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Lung Infection Caused by <span class="elsevierStyleItalic">Lophomonas blattarum</span>" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1572 "Ancho" => 1207 "Tamanyo" => 198430 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Lophomonas blattarum</span> vista microscópica.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Nathalie Pinos Vélez, Ricardo Ordoñez Vintimilla, Solmayra Agreda Orellana" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Nathalie" "apellidos" => "Pinos Vélez" ] 1 => array:2 [ "nombre" => "Ricardo" "apellidos" => "Ordoñez Vintimilla" ] 2 => array:2 [ "nombre" => "Solmayra" "apellidos" => "Agreda Orellana" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212921002263" "doi" => "10.1016/j.arbr.2021.06.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212921002263?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289620305445?idApp=UINPBA00003Z" "url" => "/03002896/0000005700000009/v1_202109020750/S0300289620305445/v1_202109020750/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0300289621000193" "issn" => "03002896" "doi" => "10.1016/j.arbres.2021.01.002" "estado" => "S300" "fechaPublicacion" => "2021-09-01" "aid" => "2722" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Arch Bronconeumol. 2021;57:592" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical Image</span>" "titulo" => "Jelly-like Pleural Effusions: An Uncommon Manifestation of Pseudomyxoma Peritonei" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "592" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Derrames pleurales gelatinosos: una manifestación infrecuente del pseudomixoma peritoneal" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1570 "Ancho" => 1500 "Tamanyo" => 488514 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Chest CT scan showed massive pleural effusions on the right side with local atelectasis of the right lung (A). Abdominal CT scan revealed multiple low-density shadows of unequal size in the liver, and the edge of the lesions were slightly enhanced (B). An open thoracotomy revealed 1500<span class="elsevierStyleHsp" style=""></span>ml free mucus in the right pleural space (C), and multiple masses along the pleura, diaphragm and liver (D). Postoperative pathological showed low-grade mucinous neoplasm (E).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Yimin Ma, Zhenguo Qiao, Haidong Chen" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Yimin" "apellidos" => "Ma" ] 1 => array:2 [ "nombre" => "Zhenguo" "apellidos" => "Qiao" ] 2 => array:2 [ "nombre" => "Haidong" "apellidos" => "Chen" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289621000193?idApp=UINPBA00003Z" "url" => "/03002896/0000005700000009/v1_202109020750/S0300289621000193/v1_202109020750/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and Workflow" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "593" "paginaFinal" => "594" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Laura Carrasco Hernández, Candela Caballero Eraso, María Abad Arranz, Eduardo Márquez Martín, Carmen Calero Acuña, Jose Luis Lopez-Campos" "autores" => array:6 [ 0 => array:3 [ "nombre" => "Laura" "apellidos" => "Carrasco Hernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Candela" "apellidos" => "Caballero Eraso" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "María" "apellidos" => "Abad Arranz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "Eduardo" "apellidos" => "Márquez Martín" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "Carmen" "apellidos" => "Calero Acuña" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 5 => array:4 [ "nombre" => "Jose Luis" "apellidos" => "Lopez-Campos" "email" => array:1 [ 0 => "lopezcampos@separ.es" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Unidad Médico-Quirúrgica de Enfermedades Respiratorias. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/Universidad de Sevilla, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Registro y análisis en el tiempo de resultados clínicos en EPOC (Proyecto TRACE): metodología y procedimiento" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Over the last few decades, several observational prospective cohorts have added to our understanding of the clinical presentation and the progression of chronic obstructive pulmonary disease (COPD). Although the different studies available have provided valuable information on specific aspects of the disease over a fixed period of time,<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">1,2</span></a> its direct implications for daily clinical practice have been less profound than expected partly due to the use of specific advanced diagnostic tools, which are not always routinely available in clinical practice. Accordingly, it would be desirable to conduct a prospective observational cohort study evaluating the tools normally available to the clinician in their daily clinical practice.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The <span class="elsevierStyleItalic">Time-based Register and Analysis of COPD Endpoints</span> (TRACE) cohort (clinicaltrials.gov <a href="ctgov:NCT03485690">NCT03485690</a>) is a single-center, prospective cohort study aimed at evaluating COPD patients prospectively using tools normally used in the clinic. The study starts from the hypothesis that is possible to identify different patient types with different clinical behavior who show a different response to treatment by using common clinical tools available at all health centers attending patients with respiratory diseases. The protocol has been approved by the Local Ethical Health Authorities (Portal de Ética de la Investigación Biomédica de Andalucía, approval actas 08/2015 and 07/2017). Due to the observational and non-interventional nature of the study, an informed consent was waived. The ethical committee was notified of this circumstance and approved the procedure clearly recorded in the protocol.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The objective of the study is to accomplish three specific aims: (1) to describe the variation over time of different clinical variables and the results of the complementary tests routinely used in the clinic, (2) to define the different behavior patterns of the disease, and (3) to evaluate the impact of different therapeutic approaches on this behavior in the different patient types in terms of lung function improvement, perception of symptoms and exacerbation frequency. The primary endpoint is survival. The secondary endpoints include dyspnea, measured by modified Medical Research Council scale, the number of moderate or severe exacerbations, forced expiratory volume in one second (FEV<span class="elsevierStyleInf">1</span>) annual decline, forced expiratory flow at 25–75% of expiration, peak expiratory flow, peripheral blood eosinophils count, serum alpha1-antitrypsin, total IgE, bronchial colonization, and inhaled and oral COPD-related medication use.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The study population is composed solely of COPD patients recruited from specialized COPD-dedicated outpatient clinics in a tertiary university hospital. Estimated sample size was 1440 cases. Adult patients with a diagnosis of COPD according to current guidelines<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">3</span></a> receiving routine follow-up in our dedicated COPD outpatient clinic have been selected for inclusion. The protocol does not pre-specify any exclusion criteria, except for the complete reversibility of lung function testing during follow-up. The inclusion of patients was piloted study since 2012, a procedure that was completed in 2015.</p><p id="par0025" class="elsevierStylePara elsevierViewall">After identification of cases, the patients are followed up at yearly visits <span class="elsevierStyleItalic">sine die</span> until they die or are lost to follow-up. The study is guided by a Steering Committee, consisting of six academic respiratory physicians who attend patients regularly. All the subjects receive their prescribed medication and therapeutic interventions throughout the study with any changes in medication being ordered by the physician in charge, according to the patient's clinical status. During the yearly visits, clinical, functional, radiological and analytical information is recorded using a standardized questionnaire.</p><p id="par0030" class="elsevierStylePara elsevierViewall">All the clinical variables were obtained from the patient and included: socio-demographics (gender, age), tobacco history, comorbidities, clinical presentation during the previous year in a stable state (including dyspnea evaluation, cough and sputum production, color of the sputum if present, wheezing and symptoms suggestive of asthma), exacerbations and hospitalization in the previous year, current pharmacological and non-pharmacological treatment. Complementary tests, included, at least, chest radiology, pre- and post-bronchodilator spirometry and analytical results (blood eosinophils, alpha1-antitrypsin, total IgE). With this information, the patients are initially categorized according to the different versions of the Global Initiative of Obstructive Lung Disease (GOLD) document<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">3</span></a> and the Spanish national guidelines for COPD (GesEPOC),<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">4</span></a> and the classification is adapted to the successive updates of these documents during the follow-up, whenever possible.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Asthma-like symptoms are also recorded, including the presence of rhinitis, variability of respiratory symptoms during the year and worsening of respiratory symptoms when exposed to non-specific triggers. The comorbidities are recorded following different comorbidity composite scores, including the Charlson comorbidity index,<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">5</span></a> the COPD specific comorbidity test (COTE),<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">6</span></a> the COMorbidities in Chronic Obstructive Lung Disease (COMCOLD) index,<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">7</span></a> and the Functional Comorbidity Index.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">8</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">Exacerbations are recorded at each yearly clinical visit. For the present study, an exacerbation is defined as any increase in perceived respiratory symptoms which requires additional medication to control them. To consider two exacerbations as different episodes, a time lapse between episodes of at least 4 weeks from the end of the exacerbation or 6 weeks from the beginning is required.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">9</span></a> The information provided by the patient regarding exacerbation frequency is matched with the information in the clinical record. Emergency ward visits and hospital admissions due to exacerbations are also noted.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Non-pharmacological treatments over the previous year are noted at every visit, including the persistence of active smoking, daily exercise, and influenza and pneumococcal vaccinations. Oral and inhaled pharmacological therapies for COPD are also noted, as is the use of home-based therapies, including home mechanical ventilation, long-term oxygen therapy and nebulizers.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Spirometries are performed so far with a Masterlab Pneumatic Tachograph (Erich Jaeger GHBH, Würzburg, Germany). The spirometer is calibrated daily, and the results adjusted by the atmospheric conditions. Patients are instructed to withhold their inhaler medication on the day of the test, in order to record pre- and post-bronchodilator spirometry. If this is not the case, then the spirometry is considered post-bronchodilator. The bronchodilator test is performed after the administration of 400<span class="elsevierStyleHsp" style=""></span>μg of salbutamol via a pressured metered dose inhaler with a chamber. The spirometry is performed according to current standards assessing the quality of the results. Parameters recorded in absolute values and percentage predicted values are forced vistal capacity (FVC), FEV<span class="elsevierStyleInf">1</span>, FEV<span class="elsevierStyleInf">1</span>/FVC ratio, peak expiratory flow, and forced expiratory flow between 25% and 75% of the FVC. The main limitation is in relation to the non-use of advanced diagnostic techniques beyond those recommended for clinical practice.</p><p id="par0055" class="elsevierStylePara elsevierViewall">TRACE is a prospective cohort study is an opportunity to identify specific patients who have a specific response to various treatments using tools available to any clinician. Their results may provide new information on how to make a more personalized medicine in real clinical practice.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Final declarations</span><p id="par0060" class="elsevierStylePara elsevierViewall">Funding. TRACE is funded by an unrestricted grant from Gebro Pharma laboratories.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Conflicts of interest</span><p id="par0065" class="elsevierStylePara elsevierViewall">JLLC has received honoraria during the last 3 years for lecturing, scientific advice, participation in clinical studies or writing for publications for (alphabetical order): AstraZeneca, Boehringer Ingelheim, Chiesi, CSL Behring, Esteve, Ferrer, Gebro, GlaxoSmithKline, Grifols, Menarini, Novartis, Rovi, and Teva.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Final declarations" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflicts of interest" ] 2 => array:2 [ "identificador" => "xack552926" "titulo" => "Acknowledgment" ] 3 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:9 [ 0 => array:3 [ "identificador" => "bib0050" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.E. Wacker" 1 => "K. Kitzing" 2 => "R.A. Jorres" 3 => "R. Leidl" 4 => "H. Schulz" 5 => "S. Karrasch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2147/COPD.S141852" "Revista" => array:6 [ "tituloSerie" => "Int J Chron Obstruct Pulmon Dis" "fecha" => "2017" "volumen" => "12" "paginaInicial" => "3437" "paginaFinal" => "3448" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29270005" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0055" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Accuracy of a new algorithm to identify Asthma-COPD Overlap (ACO) patients in a cohort of patients with chronic obstructive airway disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L. Perez de Llano" 1 => "B.G. Cosio" 2 => "M. Miravitlles" 3 => "V. Plaza" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2017" "itemHostRev" => array:3 [ "pii" => "S0008418217313327" "estado" => "S300" "issn" => "00084182" ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0060" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.F. Vogelmeier" 1 => "G.J. Criner" 2 => "F.J. Martinez" 3 => "A. Anzueto" 4 => "P.J. Barnes" 5 => "J. Bourbeau" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2017.02.001" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2017" "volumen" => "53" "paginaInicial" => "128" "paginaFinal" => "149" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28274597" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0065" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological treatment of stable phase" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Miravitlles" 1 => "J.J. Soler-Cataluna" 2 => "M. Calle" 3 => "J. Molina" 4 => "P. Almagro" 5 => "J.A. Quintano" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2017" "volumen" => "53" "paginaInicial" => "324" "paginaFinal" => "335" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0070" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A new method of classifying prognostic comorbidity in longitudinal studies: development and validation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.E. Charlson" 1 => "P. Pompei" 2 => "K.L. Ales" 3 => "C.R. MacKenzie" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Chronic Dis" "fecha" => "1987" "volumen" => "40" "paginaInicial" => "373" "paginaFinal" => "383" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0075" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Divo" 1 => "C. Cote" 2 => "J.P. de Torres" 3 => "C. Casanova" 4 => "J.M. Marin" 5 => "V. Pinto-Plata" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2012" "volumen" => "186" "paginaInicial" => "155" "paginaFinal" => "161" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0080" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Frei" 1 => "P. Muggensturm" 2 => "N. Putcha" 3 => "L. Siebeling" 4 => "M. Zoller" 5 => "C.M. Boyd" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Epidemiol" "fecha" => "2014" "volumen" => "67" "paginaInicial" => "904" "paginaFinal" => "911" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0085" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The development of a comorbidity index with physical function as the outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D.L. Groll" 1 => "T. To" 2 => "C. Bombardier" 3 => "J.G. Wright" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jclinepi.2004.10.018" "Revista" => array:6 [ "tituloSerie" => "J Clin Epidemiol" "fecha" => "2005" "volumen" => "58" "paginaInicial" => "595" "paginaFinal" => "602" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15878473" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0090" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.J. Soler-Cataluna" 1 => "R. Rodriguez-Roisin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "COPD" "fecha" => "2010" "volumen" => "7" "paginaInicial" => "276" "paginaFinal" => "284" ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack552926" "titulo" => "Acknowledgment" "texto" => "<p id="par0070" class="elsevierStylePara elsevierViewall">The authors are thankful to Hispamed Servicios Biomedicos (<a target="_blank" href="https://www.hispamed.com/">https://www.hispamed.com/</a>) for their assistance in improving the English in the original version.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/03002896/0000005700000009/v1_202109020750/S0300289620305159/v1_202109020750/en/main.assets" "Apartado" => array:4 [ "identificador" => "49741" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Scientific Letters / Cartas científicas" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005700000009/v1_202109020750/S0300289620305159/v1_202109020750/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289620305159?idApp=UINPBA00003Z" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 5 | 3 | 8 |
| 2024 October | 36 | 19 | 55 |
| 2024 September | 41 | 16 | 57 |
| 2024 August | 52 | 37 | 89 |
| 2024 July | 37 | 17 | 54 |
| 2024 June | 56 | 20 | 76 |
| 2024 May | 69 | 31 | 100 |
| 2024 April | 44 | 15 | 59 |
| 2024 March | 38 | 15 | 53 |
| 2024 February | 34 | 23 | 57 |
| 2024 January | 33 | 22 | 55 |
| 2023 December | 25 | 25 | 50 |
| 2023 November | 31 | 19 | 50 |
| 2023 October | 41 | 28 | 69 |
| 2023 September | 36 | 27 | 63 |
| 2023 August | 40 | 27 | 67 |
| 2023 July | 48 | 23 | 71 |
| 2023 June | 31 | 16 | 47 |
| 2023 May | 38 | 15 | 53 |
| 2023 April | 42 | 37 | 79 |
| 2023 March | 53 | 29 | 82 |
| 2023 February | 45 | 16 | 61 |
| 2023 January | 26 | 28 | 54 |
| 2022 December | 62 | 24 | 86 |
| 2022 November | 65 | 33 | 98 |
| 2022 October | 73 | 28 | 101 |
| 2022 September | 50 | 24 | 74 |
| 2022 August | 50 | 47 | 97 |
| 2022 July | 44 | 39 | 83 |
| 2022 June | 43 | 31 | 74 |
| 2022 May | 50 | 37 | 87 |
| 2022 April | 77 | 42 | 119 |
| 2022 March | 68 | 38 | 106 |
| 2022 February | 24 | 22 | 46 |
| 2022 January | 2 | 0 | 2 |
| 2021 December | 1 | 2 | 3 |
| 2021 October | 11 | 4 | 15 |
| 2021 September | 15 | 14 | 29 |
| 2021 March | 5 | 2 | 7 |
| 2021 February | 3 | 2 | 5 |
| 2020 December | 6 | 7 | 13 |
| 2020 November | 1 | 2 | 3 |
Show all
